Haitong M&A Capital Management

Haitong M&A Capital Management is a direct subsidiary of Haitong Securities, one of China's oldest full-service brokerages founded in 1988. It functions as the group's dedicated platform for M&A-linked private equity, restructuring, and industrial consolidation funds, distinct from Haitong's broader asset management and proprietary trading operations.

The firm focuses on control-oriented and significant-minority private equity deals tied to corporate restructuring, state-owned enterprise reform, cross-border M&A by Chinese companies, and pre-IPO growth rounds. It is structured to combine M&A advisory capabilities with direct investment, targeting politically prioritized sectors like advanced manufacturing and healthcare.

Details of its fundraising are not publicly transparent. Given its integration with a state-linked brokerage, capital likely comes from a mix of the parent's balance sheet, domestic institutional limited partners, and government-guided funds. The unit does not appear to operate a visible third-party fundraising apparatus comparable to independent global private equity firms.

The firm is predominantly focused on mainland China, with additional capacity for cross-border transactions involving outbound Chinese capital — leveraging Haitong Securities' international presence. Sector emphasis aligns with Chinese industrial policy, including advanced manufacturing, technology, and healthcare, with a distinctive appetite for complex carve-outs and state-owned enterprise restructuring.

Haitong M&A Capital Management does not appear to maintain a standalone public profile separate from its parent's consolidated reporting. Its activities, team size, and assets are likely embedded within Haitong Securities' alternative investment segment, which obscures unit-level detail from external observers and data providers.